Literature DB >> 17349430

ADAPT trial data.

John Breitner, Denis Evans, Constantine Lyketsos, Barbara Martin, Curtis Meinert.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17349430      PMCID: PMC1931835          DOI: 10.1016/j.amjmed.2006.09.022

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  1 in total

1.  Cardiovascular and cerebrovascular events in the randomized, controlled Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT).

Authors: 
Journal:  PLoS Clin Trials       Date:  2006-11-17
  1 in total
  4 in total

1.  Tannic acid is a natural β-secretase inhibitor that prevents cognitive impairment and mitigates Alzheimer-like pathology in transgenic mice.

Authors:  Takashi Mori; Kavon Rezai-Zadeh; Naoki Koyama; Gary W Arendash; Haruyasu Yamaguchi; Nobuto Kakuda; Yuko Horikoshi-Sakuraba; Jun Tan; Terrence Town
Journal:  J Biol Chem       Date:  2012-01-04       Impact factor: 5.157

2.  Alzheimer's Disease Anti-inflammatory Prevention Trial: design, methods, and baseline results.

Authors:  Curtis L Meinert; Lee D McCaffrey; John C S Breitner
Journal:  Alzheimers Dement       Date:  2009-03       Impact factor: 21.566

3.  Ferulic acid is a nutraceutical β-secretase modulator that improves behavioral impairment and alzheimer-like pathology in transgenic mice.

Authors:  Takashi Mori; Naoki Koyama; Marie-Victoire Guillot-Sestier; Jun Tan; Terrence Town
Journal:  PLoS One       Date:  2013-02-08       Impact factor: 3.240

Review 4.  Alzheimer's disease risk alleles in TREM2 illuminate innate immunity in Alzheimer's disease.

Authors:  Todd E Golde; Wolfgang J Streit; Paramita Chakrabarty
Journal:  Alzheimers Res Ther       Date:  2013-05-21       Impact factor: 6.982

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.